↓ Skip to main content

An oncoinformatics study to predict the inhibitory potential of recent FDA-approved anti-cancer drugs against human Polo-like kinase 1 enzyme: a step towards dual-target cancer medication

Overview of attention for article published in 3 Biotech, February 2019
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter
7 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
16 Mendeley